Understanding Considerations Impacting JAK Inhibitor Selection for Atopic Dermatitis Atopic dermatitis (AD) affects millions globally, with moderate to severe cases leading to significant treatment challenges. Recent…
New Breakthrough in Alopecia Areata Treatment: Deuruxolitinib Shows Promising Results Overview of Deuruxolitinib Recent studies have illuminated the benefits of deuruxolitinib, a selective Janus Kinase (JAK)…
Significant Advances in Alopecia Areata Treatment Presented at EADV Congress MUMBAI, India & PRINCETON, N.J. – Sept. 26, 2024 – Sun Pharmaceutical Industries Limited has unveiled…
